Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Interesting report of heavily pretreated relapsed/refractory Waldenström macroglobulinemia pt treated w/ teclistamab who achieved rapid and deep hematologic CR w/ complete eradication of clonal PCs and B cells in the BM.”
Title: Teclistamab in relapsed/refractory Waldenström macroglobulinemia
Authors: Michal Kascak, Ludmila Muronova, Ondrej Venglar, Gabriela Kascakova, Eva Radova, Lucie Broskevicova, Tereza Popkova, Katerina Karasova, Tereza Novakova, Jana Mihályová, Juraj Duras, Pavlina Kusnierova, Martin Havel, Tereza Sevcikova, David Zihala, Roman Hajek, Tomas Jelinek
You can read the Full Article on Haematologica.
You can find other articles featuring Robert Orlowski on OncoDaily.
